Departamento de Bioquímica y Biología Molecular IV, E.U. Óptica, Universidad Complutense de Madrid, Madrid, Spain.
Br J Pharmacol. 2012 Feb;165(4b):1163-72. doi: 10.1111/j.1476-5381.2011.01586.x.
P2 receptors are involved in the regulation of ocular physiological processes like intraocular pressure (IOP). In the present study, the involvement of P2Y(2) receptors in the hypertensive effect of nucleotides was investigated by use of antagonists and of a siRNA designed for the P2Y(2) receptor.
Agonists of the P2Y(2) receptor a as well as P2 antagonists were applied to eyes of New Zealand rabbits, and the changes in IOP were followed for up to 6 h. Cloning of the P2Y(2) receptor cDNA was done using a combination of degenerate reverse transcription PCR (RT-PCR) and rapid amplification of cDNA ends (RACE). siRNA was synthesized and tested by immunohistochemistry.
Single doses of 2-thioUTP, UTP-γ-S and UTP increased IOP. This behaviour was concentration-dependent and partially antagonized by reactive blue 2. Silencing the P2Y(2) receptor was observed in the ciliary body by immunohistochemistry labelling, where a reduction in the immunofluorescence was observed. This reduction in the expression of the P2Y(2) receptor was concomitant with a reduction in IOP, which was measurable 24 h after treatment with the siRNA, maximal after 2 days, followed by a slow increase towards control values for the following 5 days. Application of the P2Y(2) agonists after pretreatment of the animals with this siRNA did not produce any change in IOP.
P2Y(2) receptors increase IOP in New Zealand rabbits. The application of a siRNA for this receptor significantly reduced IOP, suggesting that this technology might be used for the treatment of glaucoma.
P2 受体参与调节眼内压(IOP)等生理过程。本研究通过使用拮抗剂和针对 P2Y(2)受体的 siRNA,研究了 P2Y(2)受体在核苷酸致高血压效应中的作用。
将 P2Y(2)受体激动剂 a 以及 P2 拮抗剂应用于新西兰兔眼,观察 IOP 的变化,最长可达 6 小时。采用简并逆转录 PCR(RT-PCR)和快速扩增 cDNA 末端(RACE)的方法克隆 P2Y(2)受体 cDNA。siRNA 通过免疫组织化学进行合成和测试。
单次给予 2-硫代尿苷三磷酸(2-thioUTP)、UTP-γ-S 和 UTP 均可升高 IOP。这种作用呈浓度依赖性,部分被反应性蓝 2 拮抗。免疫组织化学标记观察到睫状体 P2Y(2)受体的沉默,观察到免疫荧光减弱。这种 P2Y(2)受体表达的减少与 IOP 的降低同时发生,在 siRNA 处理后 24 小时即可测量到,2 天后达到最大值,随后在接下来的 5 天内缓慢增加至对照值。在用这种 siRNA 预处理动物后,应用 P2Y(2)激动剂不会引起 IOP 的任何变化。
P2Y(2)受体可使新西兰兔眼内压升高。针对该受体的 siRNA 的应用显著降低了 IOP,提示该技术可能用于治疗青光眼。